Cargando…

Three-Dimensional Heart Segmentation and Absolute Quantitation of Cardiac (123)I-metaiodobenzylguanidine Sympathetic Imaging Using SPECT/CT

Background: A three-dimensional (3D) approach to absolute quantitation of (123)I-metaiodobenzylguanidine (MIBG) sympathetic nerve imaging using single-photon emission tomography (SPECT) / computed tomography (CT) is not available. Therefore, we calculated absolute cardiac counts and standardized upt...

Descripción completa

Detalles Bibliográficos
Autores principales:	Saito, Shintaro, Nakajima, Kenichi, Shibutani, Takayuki, Wakabayashi, Hiroshi, Yoneyama, Hiroto, Konishi, Takahiro, Mori, Hiroshi, Takata, Aki, Kinuya, Seigo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Japanese Society of Nuclear Cardiology 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10696146/ http://dx.doi.org/10.17996/anc.23-00002

Ejemplares similares

Convolutional neural network-based automatic heart segmentation and quantitation in (123)I-metaiodobenzylguanidine SPECT imaging
por: Saito, Shintaro, et al.
Publicado: (2021)

Is (123)I-metaiodobenzylguanidine heart-to-mediastinum ratio dependent on age? From Japanese Society of Nuclear Medicine normal database
por: Nakajima, Kenichi, et al.
Publicado: (2018)

Multicenter cross-calibration of I-123 metaiodobenzylguanidine heart-to-mediastinum ratios to overcome camera-collimator variations
por: Nakajima, Kenichi, et al.
Publicado: (2014)

Ability of artificial intelligence to diagnose coronary artery stenosis using hybrid images of coronary computed tomography angiography and myocardial perfusion SPECT
por: Yoneyama, Hiroto, et al.
Publicado: (2019)

Phantom-Based Standardization Method for (123)I-metaiodobenzylguanidine Heart-to-Mediastinum Ratio Validated by D-SPECT Versus Anger Camera
por: Yamashita, Shozo, et al.
Publicado: (2023)

Impact of iterative reconstruction with resolution recovery in myocardial perfusion SPECT: phantom and clinical studies
por: Okuda, Koichi, et al.
Publicado: (2019)

Volumetric evaluation of (99m)Tc-pyrophosphate SPECT/CT for transthyretin cardiac amyloidosis: Methodology and correlation with cardiac functional parameters
por: Watanabe, Satoru, et al.
Publicado: (2021)

Transthyretin amyloid cardiomyopathy disease burden quantified using (99m)Tc-pyrophosphate SPECT/CT: volumetric parameters versus SUVmax ratio at 1 and 3 hours
por: Watanabe, Satoru, et al.
Publicado: (2023)

Comparison of diagnostic performance of four software packages for phase dyssynchrony analysis in gated myocardial perfusion SPECT
por: Okuda, Koichi, et al.
Publicado: (2017)

Utility of (123)I-MIBG Standardized Uptake Value in Patients with Refractory Pheochromocytoma and Paraganglioma
por: Wakabayashi, Hiroshi, et al.
Publicado: (2019)

Serial examination of cardiac function and perfusion in growing rats using SPECT/CT for small animals
por: Hiromasa, Tomo, et al.
Publicado: (2020)

Assessment of right ventricular sympathetic dysfunction in patients with arrhythmogenic right ventricular cardiomyopathy: An (123)I-metaiodobenzylguanidine SPECT/CT study
por: Todica, Andrei, et al.
Publicado: (2018)

Complete remission of metastatic pheochromocytoma in (123)I-metaiodobenzylguanidine scintigraphy after a single session of (131)I-metaiodobenzylguanidine therapy: a case report
por: Sugino, Teruaki, et al.
Publicado: (2017)

(123)I-Labelled metaiodobenzylguanidine for the evaluation of cardiac sympathetic denervation in early stage amyloidosis
por: Noordzij, Walter, et al.
Publicado: (2012)

Iodine-131 Metaiodobenzylguanidine Therapy for Neuroblastoma: Reports So Far and Future Perspective
por: Kayano, Daiki, et al.
Publicado: (2015)

I-131-Metaiodobenzylguanidine therapy with allogeneic cord blood stem cell transplantation for recurrent neuroblastoma
por: Sato, Yuya, et al.
Publicado: (2012)

Feasibility of High-dose Iodine-131-metaiodobenzylguanidine Therapy for High-risk Neuroblastoma Preceding Myeloablative Chemotherapy and Hematopoietic Stem Cell Transplantation: a Study Protocol
por: Araki, Raita, et al.
Publicado: (2018)

Iodine-123-metaiodobenzylguanidine cardiac SPECT imaging in the qualification of heart failure patients for ICD implantation
por: Teresińska, Anna
Publicado: (2018)

Changes in cardiac sympathetic nerve activity on (123)I‐metaiodobenzylguanidine scintigraphy after MitraClip therapy
por: Fukuda, Keisuke, et al.
Publicado: (2021)

Machine learning-based prediction of conversion coefficients for I-123 metaiodobenzylguanidine heart-to-mediastinum ratio
por: Okuda, Koichi, et al.
Publicado: (2023)

Imaging Somatostatin Receptor Activity in Neuroendocrine-differentiated Prostate Cancer
por: Mori, Hiroshi, et al.
Publicado: (2018)

(123)I metaiodobenzylguanidine (MIBG) uptake predicts early relapse of neuroblastoma using semi-quantitative SPECT/CT analysis
por: Kitamura, Yoshiyuki, et al.
Publicado: (2021)

Methods of calculating (123)I-β-methyl-P-iodophenyl-pentadecanoic acid washout rates in triglyceride deposit cardiomyovasculopathy
por: Chen, Zhuoqing, et al.
Publicado: (2022)

Uptake Index of (123)I-metaiodobenzylguanidine Myocardial Scintigraphy for Diagnosing Lewy Body Disease
por: Kamiya, Yoshito, et al.
Publicado: (2017)

The usefulness of SwiftScan technology for bone scintigraphy using a novel anthropomorphic phantom
por: Shibutani, Takayuki, et al.
Publicado: (2021)

(123)I‐Metaiodobenzylguanidine Myocardial Scintigraphy in Discriminating Degenerative Parkinsonisms
por: Catalan, Mauro, et al.
Publicado: (2021)

Calibrated scintigraphic imaging procedures improve quantitative assessment of the cardiac sympathetic nerve activity
por: Okuda, Koichi, et al.
Publicado: (2020)

Machine learning-based risk model using (123)I-metaiodobenzylguanidine to differentially predict modes of cardiac death in heart failure
por: Nakajima, Kenichi, et al.
Publicado: (2020)

Quality and utility of [(123)I]I-metaiodobenzylguanidine cardiac SPECT imaging in nondiabetic postinfarction heart failure patients qualified for implantable cardioverter defibrillator
por: Teresińska, Anna, et al.
Publicado: (2021)

Autonomic disorders and myocardial 123I-metaiodobenzylguanidine scintigraphy in Huntington’s disease
por: Assante, Roberta, et al.
Publicado: (2020)

Clinical performance and radiation dosimetry of no-carrier-added vs carrier-added (123)I-metaiodobenzylguanidine (MIBG) for the assessment of cardiac sympathetic nerve activity
por: Verberne, Hein J., et al.
Publicado: (2008)

Cross calibration of (123)I-meta-iodobenzylguanidine heart-to-mediastinum ratio with D-SPECT planogram and Anger camera
por: Nakajima, Kenichi, et al.
Publicado: (2017)

(123)I-Meta-iodobenzylguanidine Sympathetic Imaging: Standardization and Application to Neurological Diseases
por: Nakajima, Kenichi, et al.
Publicado: (2016)

A prediction model for 5-year cardiac mortality in patients with chronic heart failure using (123)I-metaiodobenzylguanidine imaging
por: Nakajima, Kenichi, et al.
Publicado: (2014)

Diagnosis of Parkinson syndrome and Lewy-body disease using (123)I-ioflupane images and a model with image features based on machine learning
por: Nakajima, Kenichi, et al.
Publicado: (2022)

I -123 metaiodobenzylguanidine imaging for predicting ventricular arrhythmia in heart failure patients
por: Zhou, Weihua, et al.
Publicado: (2013)

Thyroid function after diagnostic (123)I-metaiodobenzylguanidine in children with neuroblastic tumors
por: Clement, Sarah C., et al.
Publicado: (2022)

Impact of mediastinal, liver and lung (123)I-metaiodobenzylguanidine ((123)I-MIBG) washout on calculated (123)I-MIBG myocardial washout
por: Verberne, Hein J., et al.
Publicado: (2009)

Myocardial perfusion imaging with retrospective gating and integrated correction of attenuation, scatter, respiration, motion, and arrhythmia
por: Nakajima, Kenichi, et al.
Publicado: (2023)

Prediction of outcomes in MCI with (123)I-IMP-CBF SPECT: a multicenter prospective cohort study
por: Ito, Kengo, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_9d90kiv8lao72r7nlmte2odtoi